Skip to main content
. 2002 Sep;107(1):39–45. doi: 10.1046/j.1365-2567.2002.01452.x

Table 1. Analysis of tumour derived V genes*.

VH VL


Patient Immunoglobulin V-gene % homology* JH V-gene % homology* JL
I GH IgGλ V4–59 90·9 JH4b VλIII (IGLV3S6) 89·6 Jλ2
II JC IgAκ V3–23 93·8 JH4b VκIII (A27) 95·1 Jκ2
III GS IgGκ V3–7 88·8 JH4b VκI (012/02) 88·9 Jκ5
IV JW IgGκ V2–70 96·6 JH4b VκIII (38 k/L6) 97 Jκ2
V MW IgGκ V5–51 95·5 JH4b VκI (018/08) 95·8 Jκ2
VI PR IgGλ V2(S12–4) 93·3 JH3b VλI (1c/DPL2) 94·7 Jλ7
VII WD IgGκ V2(S12–4) 92·5 JH5b VκI (02/DPK9) 90·9 Jκ1
VIII FA IgGκ V2(S12–7) 86·6 JH4b VκIII (38 k/L6) 95·4 Jκ4
IX PC IgGκ V1–3 88·4 JH6b VκI (02/DPK9) 95·8 Jκ3
*

Nucleotide sequences have been deposited in the GenBank/EMBL database: accession numbers are AF442750–67.